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Human immunodeficiency virus (HIV) infection is an established risk factor for pulmonary 26 
arterial hypertension (PAH), however the pathogenesis of HIV-related PAH remains unclear. 27 
Since K
+
 channel dysfunction is a common marker in most forms of PAH, our aim was to 28 
analyse if the expression of HIV proteins is associated with impairment of K
+
 channel function 29 
in the pulmonary vascular bed. HIV transgenic mice (Tg26) expressing seven of the nine HIV 30 
viral proteins and wild type (Wt) mice were used. Hemodynamic assessment was performed by 31 
echocardiography and catheterization. Vascular reactivity was studied in endothelium-intact 32 
pulmonary arteries (PA). K
+
 currents were recorded in freshly isolated PA smooth muscle cells 33 
(PASMC) using the patch-clamp technique. Gene expression was assessed using qRT-PCR. 34 
PASMC from Tg26 mice had reduced K
+
 currents and were more depolarized that those from 35 
Wt. While Kv1.5 currents were preserved, pH-sensitive non-inactivating background currents 36 
(IKN) were nearly abolished in PASMC from Tg26 mice. Tg26 mice had reduced lung expression 37 
of Kv7.1 and Kv7.4 channels and decreased responses to the Kv7.1 channel activator L634,373 38 
assessed by vascular reactivity and patch-clamp experimental approaches. While we found 39 
pulmonary vascular remodeling and endothelial dysfunction in Tg26 mice, this was not 40 
accompanied by changes in hemodynamic parameters. In conclusion, the expression of HIV 41 
proteins in vivo impairs pH-sensitive IKN and Kv7 currents. This negative impact of HIV proteins 42 
in K
+
 channels, was not sufficient to induce PAH, at least in mice, but may play a permissive or 43 
accessory role in the pathophysiology of HIV-associated PAH. 44 
 45 
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The human immunodeficiency virus (HIV) infection and its associated pathologies constitute a 50 
global health concern. It is estimated that around 37 million people are living with HIV globally 51 
(UNAIDS, 2017). Despite the success of highly active antiretroviral therapy, chronic 52 
inflammation persists and is independently associated with cardiovascular complications (44). 53 
Among the cardiovascular complications, HIV-associated pulmonary arterial hypertension 54 
(PAH) is especially severe and is associated with significant morbidity and mortality (4). 55 
Moreover, HIV patients have a 2500-fold increased risk of developing PAH and have a poorer 56 
prognosis than PAH in the general population (9). While only a small proportion (0.46%) of 57 
patients with HIV will develop HIV related PAH (42), there may be as many as 200,000 HIV-58 
infected patients affected by PAH worldwide.  59 
 60 
PAH is a complex disorder characterized by excessive vasoconstriction, inflammation and 61 
vascular remodeling that lead to reduced lumen of pulmonary arteries (PA) 62 
and increased pulmonary vascular resistance (34). The pathogenesis of PAH is rather 63 
multifactorial but impairment of K
+
 channels is considered an early and common feature in 64 
most, if not all, forms of the disease (3, 34).  65 
 66 
A variety of K
+
 channels have been shown to play an essential role in controlling pulmonary 67 
vascular tone and their impairment results in a more depolarized membrane potential in PA 68 
smooth muscle cells (PASMC), leading to increased intracellular calcium, vasoconstriction and 69 
proliferation (3, 8). Dysfunction of K
+
 channels, particularly the voltage-gated potassium 70 
channels-Kv Kv1.5 (encoded by KCNA5) (2-3, 31, 45) and the member of the two-pore domain 71 
potassium channel TWIK-related acid-sensitive potassium channel 1 (TASK-1, encoded by 72 
KCNK3) (1, 26, 37), have been found in experimental and clinical PAH and is considered a 73 
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contributing factor in the development of the disease (3, 37). During the last decade Kv7 74 
(Kv7.1 WKv7.5) channels encoded by KCNQ1ʹ5 have emerged as key candidates to control 75 
vascular tone in several blood vessels, including the pulmonary circulation (6, 22, 24, 32). 76 
Interestingly, reduced KCNQ4 expression has been reported in early phases of hypoxia-induced 77 
pulmonary hypertension (41) but this have not been consistently confirmed in other forms of 78 
the disease. 79 
 80 
Although the mechanisms underpinning the pathophysiology of HIV-associated PAH remain 81 
still largely unknown, several HIV viral proteins have been proposed to contribute (4, 21). Thus, 82 
Nef, Tat and gp120 induce endothelial dysfunction (12, 23, 38) and have been proposed to 83 
initiate pulmonary vascular remodeling (4). Tat represses the transcription of the bone 84 
morphogenic protein receptor-2 (BMPR-2) (5), whose deficiency plays a key important role in 85 
the onset and progression of PAH (34). Vpu interacts with TASK-1 channels and disrupts its 86 
function (18) and expression of Nef has been associated with the development of complex 87 
pulmonary vascular lesions in simians (28). We hypothesized that the expression of HIV 88 
proteins is associated with impairment of K
+
 channel function in the pulmonary circulation as 89 
occurs in other forms of PAH. To address this issue, we undertook experiments using the Tg26 90 
transgenic non-infectious mice model which expresses seven of the nine proteins of the HIV. 91 
 92 
 93 
MATERIALS AND METHODS 94 
 95 
Animals. All experimental procedures utilizing animals were carried out according to the 96 
Spanish Royal Decree 1201/2005 and 53/2013 on the Care and Use of Laboratory Animals and 97 
approved by the institutional Ethical Committees of the Universidad Complutense de Madrid 98 
(Madrid, Spain) and the regional Committee for Laboratory Animals Welfare (Comunidad de 99 
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Madrid, Ref. number PROEXO-301/16). Age matched (10 weeks) male FVB/NJ (Wt) and HIV-1 100 
transgenic mice on the FVB/NJ background (FVB/N-Tg(HIV)26Aln/PkltJ; Tg26) from the Jackson 101 
Laboratory (USA) were provided by Charles River (France). This HIVǦ1 Tg26 mice model express 102 
a transgene containing a portion of the HIV including Env and Tat, Nef, Rev, Vif, Vpr, and Vpu 103 
accessory genes but lacking part of the gag-pol region, rendering the virus non-infectious (11). 104 
Animals were kept under standard conditions of temperature 22±1°C and 12:12 hour 105 
dark/light cycle with free access to food and water. 106 
 107 
Genotyping. Genomic DNA was isolated from tail biopsies of Wt and Tg26 mice with a lysis 108 
buffer of the following composition (in mmol/L): Tris.Cl ph8 10, EDTA 10, NaCl 100 and 0.5% 109 
SDS containing Proteinase K 0.1 in mg/mL for 16h at 55ºC. Then, genomic DNA was extracted 110 
with phenol/chloroform/isoamyl alcohol and purified. 100 ng of genomic DNA was used as 111 
template for standard PCR using the primers listed in Table 1 according to the genotyping 112 
protocol from The Jackson Laboratory. 113 
 114 
Tissue and cell isolation. Resistance PA were carefully dissected free of surrounding tissue and 115 
cut into rings (1.8-2 mm length). For cell isolation, PA rings were cut into small segments and 116 
placed into a nominally Ca
2+
-free physiological salt solution (PSS) of the following composition 117 
(in mmol/L): NaCl 130, KCl 5, MgCl 2 1.2, glucose 10, and HEPES 10 (pH 7.3 with NaOH) 118 
containing (in mg/mL) papain 1, dithiothreitol 0.8, and albumin 0.7 for 7-10 min. Thereafter, 119 
artery segments were incubated for an additional 3-5 min in Ca
2+
-free PSS containing (in 120 
mg/mL) collagenase F 1, collagenase H 0.3, and albumin 0.7. PA smooth muscle cells (PASMC) 121 
were dissociated using a wide bore, smooth-tipped pipette. Cells were stored in Ca
2+
-free PSS 122 
(4°C) and used within 8 h of isolation.  123 
 124 
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Recording of arterial reactivity. For contractile tension recording, PA rings were mounted in a 125 
wire myograph with Krebs buffer solution maintained at 37 °C and bubbled with 95 % O2 and 5 126 
% CO2. Vessels were stretched to give an equivalent transmural pressure of 20 mmHg. 127 
Preparations were Įrstly stimulated by raising the K+ concentration of the buffer (to 80x10-3 M) 128 
in exchange for Na
+
. Vessels were washed three times and allowed to recover before a new 129 









 M) or Kv7 channel activators were examined in arteries 131 
stimulated with serotonin (5-HT, 10
-5
 M). Contraction induced by Kv1.5 or Kv7 channel 132 
inhibitors was assayed in the absence of pretone.  133 
 134 
Electrophysiological studies. Membrane currents were recorded with an Axopatch 200B and a 135 
Digidata 1322A (Axon Instruments, Burlingame, CA, U.S.A) using the whole cell configuration of 136 
the patch-clamp technique. Total Kv currents were recorded following the application of 200 137 
ms voltage steps ranging from -60 to +20 mV (7, 30). In some experiments long (4 s) 138 
depolarizing steps were applied in order to minimize the contribution of time-dependent 139 
delayed rectifier potassium currents (such as Kv1) and maximize the contribution of Kv7 140 
currents as reported (32). Current-voltage relationships were constructed by measuring the 141 
currents at the end of the pulse. To record TASK-like currents, defined as the non-inactivating 142 
background K
+
 current (IKN), sensitive to pH, PASMC were clamped at 0 mV for 5 minutes to 143 
inactivate Kv channels and, subsequently, a 1s ramp from +60 mV to -100 mV was applied (16, 144 
36) at pH 6.3 and 7.3. To minimize activation of BKCa channels cells were superfused with an 145 
external Ca
2+
-free PSS (see above) and a Ca
2+
-free pipette (internal) solution containing 146 
(mmol/L): KCl 110, MgCl2 1.2, Na2ATP 5, HEPES 10, EGTA 10 (pH adjusted to 7.3 with KOH). 147 
Currents were normalized for cell capacitance and expressed in pA/pF as previously described 148 
(7, 30). All experiments were performed at room temperature. 149 
 150 
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PASMC culture. Primary PASMC obtained from intralobar PA explants and grown in Smooth 151 
Muscle Cell Growth Medium2 supplemented with Smooth Muscle Cell Growth Supplement (C-152 
22062, PromoCell, Germany). The smooth muscle phenotype was confirmed by positive 153 
immunofluorescent staining using an anti-ɲ-actin antibody (Sigma-Aldrich, Clone 1A4). PASMC 154 
between passages 1 or 2 were used for qRT-PCR studies.  155 
 156 
qRTʹPCR analysis. dŽƚĂůZEǁĂƐŝƐŽůĂƚĞĚĂŶĚƉƵƌŝĮĞĚeither from whole lung homogenates or 157 
from PASMC using the miRNEASY extraction kit according to manufacturer´s instructions 158 
(Qiagen, Hilden, Germany). Total RNA was reverse transcribed into cDNA using iScript TM 159 
cDNA Synthesis Kit (BioRad) following manufaĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ? ZĞĂů-time PCR was 160 
performed using a TaqMan system (Roche-Applied Biosystems, Mannheim, Germany) in the 161 
Genomic Unit of the Universidad Complutense de Madrid. Custom sense and anti-sense 162 
primers for NOS3 and BMPR2 with a Taqman probe number #56 (Roche, Cat: 04688538001) 163 
and # 67 (Roche, Cat: 0468866001), respectively and commercial primers from Applied 164 
Biosystems for KCNA5, KCNK3, KCNQ1, KCNQ4, KCNQ5, NOS3, BMPR2 and ACTB expression 165 
were used (Table 1). The DDCt method was used to quantify mRNA. Target gene expression 166 
was normalized to the expression of ACTB. 167 
 168 
Echocardiography. A two-dimensional motion-mode transthoracic echocardiography was 169 
performed at a frame rate above 230 frames/second using a Vevo 2100 system and a 30-MHz 170 
linear probe (Visualsonics, Toronto, Canada). Echocardiography examination was blindly 171 
performed by an expert operator. Colour and pulse wave (PW) Doppler were acquired with a 172 
pulse repetition frequency of 40 Kz to study pulmonary artery flows. PW Doppler was 173 
displayed just at the beginning of the pulmonary artery. The pulmonary acceleration time 174 
(PAT), ejection time (ET) and the ratio PAT/ET were measured to estimate right ventricular 175 
systolic pressure (43). Right ventricle systolic function was estimated using the tricuspid 176 
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annular plane systolic excursion (TAPSE) obtained from a d four-chamber apical view to 177 
measure maximum lateral tricuspid annulus motion. Mice were lightly anesthetized with 0.5-178 
1.5% isoflurane in oxygen to maintain the heart rate along the experiments. Mice were 179 
positioned in supine position and kept in normothermia during the experiments with a heating 180 
platform and a warmed ultrasound gel.  181 
 182 
Hemodynamic measurements. Mice were anesthetized i.p. with a mixture of 80 mg/kg 183 
ketamine (Mearial Lyon, France) plus 8 mg/kg xylacine (KVP Pharma und Veteriär-Produkte 184 
GmbH, Kiel, Germany). Before initiation of surgical procedure, general anesthesia was 185 
confirmed by assessing the absence of response to any stimulus. Then, animals were placed in 186 
a supine position on a thermostatically controlled electric heating blanket (Homeothemic 187 
Blanket Control Unit, Harvard Apparatus, March-Hugstetten, Germany) to maintain body 188 
temperature at 38°C. The tracheostomy was performed by a ventral neck incision followed by 189 
insertion of a 1.3-mm outer diameter tracheotomy cannula in the trachea. Animals were 190 
ventilated with room air (tidal volume 9 mL/Kg, 100 breaths/min, and a positive end-expiratory 191 
pressure of 2 cm H2O) with a rodent ventilator (MiniVent Type 845, Harvard Apparatus, USA). 192 
After sternotomy, ventricular systolic pressure (RVSP), and systolic, diastolic and mean 193 
pulmonary arterial pressures (sPAP, dPAP and mPAP) were measured in open-chest mice as 194 
previously reported in rats (31). Measurements were recorded with a pressure transducer via a 195 
0.7-mm internal diameter catheter (24 GA, BD Insyte, USA) introduced in the right ventricle 196 
and then advanced to the main PA. 197 
 198 
Assessment of RV hypertrophy. At the end of the recordings, hearts were excised and the right 199 
ventricle (RV) and the left ventricle plus septum (LV+S) were carefully dissected and weighed. 200 
The Fulton index [RV/(LV+S)] and the ratio RV/body weight (BW) were calculated to assess 201 
right ventricular hypertrophy (31). 202 




Lung histology. The right lung was inflated in situ with formol saline through the right bronchus 204 
and embedded in paraffin. Hematoxilyn and eosin staining and elastic Van Gieson (eVG) 205 
staining were performed in lung sections according to common histopathological procedures 206 
and examined by light microscopy. Small arteries (25 W100 µm outer diameter) were analysed 207 
in a blinded fashion and categorized as muscular, partially muscular or nonmuscular as 208 
previously described (31). Medial wall thickness was defined by the area between the external 209 
elastic lamina and the internal elastic lamina marked by eVG staining. Around 500 210 
ƌĞƉƌĞƐĞŶƚĂƚŝǀĞ ǀĞƐƐĞůƐ ǁŝƚŚŝŶ Ă ƌĂŶŐĞ ŽĨ ĚŝĂŵĞƚĞƌƐ ĨƌŽŵ  ? ? ƚŽ  ? ? ʅŵ ǁĞƌĞ ĂŶĂůǇǌĞĚ ƉĞƌ211 
sample.  212 
 213 
Reagents. Drugs and reagents were obtained from Sigma-Aldrich Quimica (Spain), except 214 
retigabine (Axon, Groningen, The Netherlands) and L-364,373 (Tocris, Bristol, UK). Drugs were 215 
ĚŝƐƐŽůǀĞĚŝŶD^KĂŶĚĨŝŶĂůǀĞŚŝĐůĞĐŽŶĐĞŶƚƌĂƚŝŽŶƐǁĞƌĞA? ? ? ?A? ? 216 
 217 
Statistical analysis. Data are expressed as mean ± S.E.M.; n indicates the number of 218 
experiments from different animals, unless otherwise stated. Statistical analysis was 219 
ƉĞƌĨŽƌŵĞĚ ƵƐŝŶŐ Ă ^ƚƵĚĞŶƚ ?Ɛ ƚ-test for paired or unpaired observations, or one-way ANOVA 220 
followed by a Newman-Keuls test for multiple comparisons. When more than one sample 221 
came from the same animal, the nested ANOVA was applied. Differences were considered 222 
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Potassium channel dysfunction in PASMC from HIV-1 mice. PASMC isolated from Tg26 mice had 227 
similar membrane capacitance (20.3 ± 0.7 pF) compared to those isolated from Wt mice (19.7 228 
± 0.6 pF; p > 0.05). Figure 1A shows original traces of the total Kv currents recorded in 229 
myocytes from both strains. Kv currents measured at the end of the 200 ms depolarizing 230 
pulses were significantly smaller in PASMC from Tg26 mice than in those from Wt mice at 231 
potentials more positive to -10 mV (Fig. 1B). Moreover, resting membrane potential was more 232 
depolarized in PASMC from Tg26 mice than in those from wild type (Fig. 1C). 233 
 234 
Kv1.5 channels are not affected in PA from Tg26 mice. We studied whether Kv1.5 currents, 235 
which represent a main component of the total Kv current in the pulmonary vasculature (30), 236 
were affected in Tg26 mice. We found that the selective Kv1.5 channel inhibitor DPO-1 (10
-6 
M) 237 
induced a marked reduction of the Kv currents in both Wt- (Fig. 2A) and Tg26- (Fig. 2B) derived 238 
PASMC. Thus, DPO-1-sensitive currents, which reflect the Kv1.5 channel component, were not 239 
significantly different in both cell types (Fig. 2C). In addition, DPO-1 had negligible effects on 240 
vascular tone in arteries isolated from both strains (Fig. 2D and E). In line with these data, the 241 
gene encoding for Kv1.5 (KCNA5) was similarly expressed in lungs (Fig. 2F) or PASMC (Fig. 2G) 242 
isolated from both strains. These data suggested that K
+
 channels, other than Kv1.5, were 243 
impaired in PA from Tg26 mice. 244 
 245 
PH-sensitive IKN currents are impaired in PA from HIV-1 Tg26 mice. Fig. 3A shows original 246 
recordings of IKN at different pH ĚƵƌŝŶŐƚŚĞĂƉƉůŝĐĂƚŝŽŶŽĨǀŽůƚĂŐĞƌĂŵƉƐĨƌŽŵ ? ?ƚŽA? ? ? ?ŵs247 
from a holding potential of 0 mV. In Wt PASMC IKN was inhibited when switching the pH of the 248 
external solution from 7.3 to 6.3. The I-V relation of the pH-sensitive current yielded a non-249 
voltage-gated current as expected for TASK-like currents (Fig. 3B). On the other hand, currents 250 
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from Tg26 mice were not inhibited by extracellular acidification (Fig. 3A and B). In addition, 251 
acidification led to membrane depolarization in Wt (Fig. 3D) but not in Tg26 (Fig. 3E) PASMC. 252 
Thus, both pH-sensitive K
+
 current (Fig. 3C) and pH-induced depolarization (Fig. 3F) were 253 
markedly attenuated in cells from Tg26 mice. These differences were unrelated to changes in 254 
the expression of KCNK3 in lungs or PASMC (Fig. 3G and H). Consistent with previous reports 255 
(35), we were unable to analyze TASK-1, the protein encoded by KCNK3, in lung samples 256 
because commercially available antibodies did not identify the protein in the Western blots. 257 
 258 
Kv7 channels are impaired in PA from HIV-1 Tg26 mice. The non-inactivating voltage-gated Kv7 259 
currents were studied by applying long (4 s) depolarizing pulses as previously reported (32). 260 
The K
+
 current measured at the end of these pulses was diminished in PASMC from Tg26 mice 261 
(Fig. 4A and B). To further characterize the role of Kv7 channels, cells were exposed to the 262 
selective Kv7 channel inhibitor XE991. At 3x10
-7 
M, this drug reduced the current in Wt- (Fig. 263 
4A and 4C) but not in Tg26- (Fig. 4A and D) derived PASMC. Thus, the current sensitive to 264 
XE991 was abrogated in PASMC from Tg26 mice (Fig. 4E). In PA isolated from Wt mice XE991 265 
(3x10
-6 
M) elicit a robust contraction that was significantly smaller in PA from Tg26 mice (Fig. 266 
4F and G). Similar results were obtained with linopirdine (10
-5
 M), another Kv7 channel 267 
inhibitor (Fig. 4H). Quantitative analysis of mRNA expression of specific genes encoding for the 268 
most predominant Kv7 channels (Kv7.1, Kv7.4 and Kv7.5) in the vascular bed revealed a 269 
reduced expression of KCNQ1 and KCNQ4, but not KCNQ5 (Fig. 5A), in lungs from Tg26 as 270 
compared to Wt mice. Thus we assessed the effects of L-364,373 which selectively activates 271 
Kv7.1 channels and retigabine that activates Kv7.2 through Kv7.5 channels. The addition of 272 
L634,373 led to an enhancement of the current in PASMC from Wt but not from Tg26 and (Fig. 273 
5B and C). On the other hand, retigabine had no effect on the current in either cell type (Fig. 274 
6A and B). We also analysed the relaxant responses induced by both drugs. The relaxation 275 
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induced by L-364,373 was significantly reduced in PA from Tg26 mice (Fig. 5D and E). However, 276 
no differences were found in the relaxant responses induced by retigabine between both Wt 277 
and Tg26 PA (Fig. 6C and D). 278 
 279 
Assessment of pulmonary hemodynamics and remodeling. Table 2 summarizes the 280 
hemodynamic parameters obtained by Doppler echocardiography in Wt and HIV-1 Tg26 mice. 281 
PAT, ET, PAT/ET and TAPSE values were similar in both strains. Fig. 7A shows original 282 
recordings of pulmonary arterial pressure by PA catheterization. In line with the 283 
echocardiography findings no differences were found in pulmonary hemodynamics (dPAP, 284 
sPAP and mPAP, Fig. 7B), RVSP (Fig. 7C) or heart rate (Fig. 7D) assessed by catheterization. The 285 
assessment on cardiac remodeling by the fulton index (RV/S+LV, Fig. 7E) or RV/body weight 286 
(Fig. 7F) revealed no significant right ventricular hypertrophy in Tg26 compared to Wt. 287 
 288 
PA from HIV-1 Tg26 exhibit endothelial dysfunction. Contractile responses induced by KCl and 289 
5-HT were similar in PA isolated from both Tg26 and Wt mice (Fig. 8A-C). We then analyzed the 290 
relaxation induced by the nitric oxide-cGMP pathway in 5-HT contracted arteries. The 291 
relaxation induced by ACh (endothelial dependent; Fig. 8D), but not that of SNP (endothelial 292 
independent, Fig. 8E), was attenuated in PA from Tg26 mice. This endothelial dysfunction was 293 
not associated with changes in the expression of genes encoding for eNOS (NOS3) or BMPR2 294 
(BMPR2) (Fig. 8G and H). We also assessed the endothelial-mediated relaxation in mesenteric 295 
arteries. Although there was a trend for reduced relaxation in mesenteric arteries from Tg26, 296 
differences did not reach statistical significance (Fig. 8F).  297 
 298 
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Fig. 9A shows representative images of hematoxylin and eosin stained lung sections from Wt 299 
and HIV-1 Tg26 mice. Pulmonary arteries were classified into non muscular, partially muscular 300 
and muscular arteries (Fig. 9B). A modest vascular remodeling consisting of an increased 301 
percentage of partially muscular and muscular PA and decreased percentage of non-muscular 302 
PA was observed in Tg26 mice. Moreover, a significant increase in medial wall thickness, 303 
assessed by the elastic Van Gieson staining, was found in Tg26 as compared to Wt mice (Fig. 9C 304 
and D).  305 
 306 
  307 





In the present study we report that HIV transgene expression leads to attenuation of 310 
endothelial-dependent relaxation and impairment of K
+
 channel activity in the pulmonary 311 
vasculature. In particular, a marked reduction of pH-sensitive IKN and Kv7 currents was found in 312 
PASMC from mice expressing HIV proteins. Our study identifies novel pathogenic factors that 313 
could play a role in the development of PAH associated to HIV. This is the first study reporting 314 
K
+
 channel dysfunction by HIV in the pulmonary circulation. 315 
 316 
With the advent of combination antiretroviral therapy, HIV-associated comorbidities like 317 
cardiovascular diseases have become a leading cause of death in HIV infected patients. Among 318 
them, PAH is a life-threatening complication of HIV infection (4). The mechanisms involved in 319 
the pathogenesis of HIV-PAH are not completely understood but HIV proteins such as Gp120, 320 
Tat, and Nef are considered candidate contributors (4, 21). Thus, to get insight into the 321 
mechanisms involved in PAH associated to HIV we took advantage of a transgenic mice 322 
expressing seven of the nine HIV proteins.  323 
 324 
Our non-invasive (by echocardiography) and invasive (by PA catheterization) hemodynamic 325 
assessments revealed that pulmonary arterial pressures were not elevated in Tg26 mice. 326 
Accordingly, we found no changes in right ventricular weight. Previous studies in HIV 327 
transgenic rats have shown elevated PA pressure and right ventricular hypertrophy (25, 29); 328 
while other study by Porter et al (40) showed that Fischer 344 rats expressing HIV proteins 329 
were normotensive, even though these animals had exacerbated PAH in response to hypoxic 330 
exposure. In comparison with these studies, animals used in our study were much younger (10 331 
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weeks versus 4-9 months) so we cannot rule out that these animals may develop PAH at older 332 
ages. But most likely the lack of PAH in HIV Tg26 mice can be attributed to the notable 333 
differences in the development of this disease between rat and mice (15). These include, 334 
among others, the development of less PA thickening and PH in mice than rats after chronic 335 
hypoxia, or the induction of reversible (in mice) versus non-reversible and fatal (in rats) PH 336 
induced by the exposition to SU5416/hypoxia (15). These data strongly suggest that the 337 
expression of HIV-1 may predispose, but appears insufficient, to induce PAH in the mouse 338 
model. Noteworthy, the majority of patients with HIV infection are also not affected of PAH. 339 
Albeit HIV-1 Tg26 mice had PA pressures similar to Wt mice, we observed changes 340 
characteristic of PAH such as pulmonary vascular remodeling, endothelial dysfunction, and K
+
 341 
channel impairment. Likewise, severe pulmonary arterial muscularization can occur in mice 342 
without the development of PAH or RV hypertrophy (10). We also found that PA from HIV-1 343 
Tg26 mice had endothelial dysfunction as demonstrated by attenuated relaxation to ACh with 344 
unaffected relaxation to SNP. Whilst similar results have been observed in large systemic 345 
arteries from HIV-1 transgenic mice (17), in our study the endothelial-dependent vasodilation 346 
was not impaired in mesenteric arteries. Several mechanisms have been proposed to account 347 
for the endothelial dysfunction in systemic arteries from HIV-associated PAH including the 348 
downregulated BMPR2 or NOS3 gene expression (5, 12, 23, 38). However, we found unaltered 349 
BMPR2 or NOS3 expression in lungs from Tg26 mice. Alternative mechanisms proposed for 350 
HIV-1-induced endothelial dysfunction, which we did not further explore, include increased 351 
production of reactive oxygen species and accelerated NO degradation (19-20) or increased 352 




 channels play a central role in governing membrane potential in PASMC and their 355 
impairment is associated with depolarization, increased vasoconstriction and proliferation (3, 356 
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8, 37). Our experiments demonstrate that total K
+
 currents are attenuated in PASMC from HIV-357 
1 Tg26 mice and this is associated with a more depolarized resting membrane potential. 358 
Among the different K
+
 channels expressed in PASMC, special attention has been given to 359 
Kv1.5 and TASK-1 channels due to their role in controlling pulmonary vascular tone and in the 360 
pathogenesis of PAH. Reduced expression and function of Kv1.5 channels is a common 361 
characteristic in many forms of human and experimental PAH (2-3, 31, 45). Similarly, Lund et al 362 
(25) found that expression of KCNA5, the gene encoding for Kv1.5 channels, is reduced in lungs 363 
from HIV-1 transgenic rats that exhibit pulmonary hypertension. Herein, we comparatively 364 
analyzed the expression and activity (using the selective inhibitor DPO-1) of Kv1.5 channels in 365 
both Wt vs HIV-1 Tg26 mice. We found that DPO-1 exerted similar effects on total Kv current 366 
and contraction in both strains strongly suggesting a similar contribution of Kv1.5 channels. 367 
Intriguingly, DPO-1 sensitive current in PASMC from Tg26 mice reached an apparent plateau at 368 
positive potentials, which could be due to the partial contribution of residual BKCa current. 369 
Likewise, no differences were found in KCNA5 expression in lungs or PASMC from Wt vs Tg26 370 
mice. The reason for the discrepancies between our and Lund´s study is unknown but may rely 371 
on different animal species used. Another possible explanation is that downregulation of 372 
KCNA5 is secondary to the development of PH, as occurred in the referred study. 373 
 374 
There is compelling evidence that impairment of TASK-1 channels (encoded by KCNK3), a 375 
member of the two-pore domain background potassium channels family, plays a role in PAH 376 
(3, 37). Thus, the association between loss of function of KCNK3 and PAH has been identified in 377 
hereditary and other forms of the disease (1, 26, 37). However, its role in PAH associated to 378 
HIV-1 remains unknown. A distinguishing feature of TASK channels is their pH dependence, 379 
thus we aimed to compare the activity of TASK channels in Wt and Tg26 mice by examining the 380 
acid-sensitivity of the background current IKN. In PASMC from Wt we found that acidification of 381 
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extracellular pH inhibited the IKN current leading to membrane depolarization, suggesting a 382 
functional role of TASK-like channels. These results are in line with previous data in rat (14), 383 
rabbit (16) or human (36) PASMC, albeit this pH sensitive current was not observed in a 384 
previous study in mouse PASMC (27). In contrast to what we observed in Wt cells, PASMC from 385 
Tg26 mice were essentially insensitive to pH. The mechanism underlying the reduced pH-386 
sensitive current in HIV-1 expressing mice remains unknown, but it is tempting to speculate a 387 
role of the HIV-1 accessory protein Vpu. It is worth highlighting that Vpu shares structural 388 
homology with the N-terminal region of the TASK channel family members, including TASK-1, 389 
and that Vpu and TASK-1 oligomerize in vitro and in lymphoid tissues from AIDS patients (18). 390 
Moreover, the coexpression of Vpu and TASK-1 in heterologous systems leads to the 391 
suppression of the TASK current. Conversely, overexpression of TASK-1 suppresses HIV-1 392 
replication (13). However, we could not confirm the protein expression of Vpu in the lung (with 393 
a commercially available antibody, ab81532). 394 
 395 
Findings from the last years suggest that Kv7 channels are key regulators of vascular tone and 396 
reduced expression and activity of Kv7 channels has been reported in several cardiovascular 397 
diseases including essential hypertension (6, 22) or diabetes (32). Kv7 channels make also an 398 
important contribution on the regulation of pulmonary vascular tone (24). Moreover, the 399 
vascular responses to Kv7 channel modulators are depressed in two murine models of 400 
pulmonary hypertension (33) suggesting a Kv7 channel impairment. In fact, reduced KCNQ4 401 
expression has been noticed in PA from rats exposed to hypoxia for 3 days, which corresponds 402 
to the onset of pulmonary hypertension development (41). Herein, we dissected the Kv7 non-403 
inactivating voltage-gated K
+
 currents by applying long depolarizing pulses and by the use of 404 
Kv7.1-7.5 channel blocker XE991. The amplitude of this Kv7 current was markedly reduced in 405 
PASMC from Tg26 mice. Accordingly, XE991 as well as another Kv7 channel blocker linopirdine 406 
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elicited greater vasoconstrictor responses in PA from Wt than from Tg26. To ascertain if these 407 
differences were related to loss of channel expression in Tg26 lungs we analyzed the gene 408 
expression of the most relevant Kv7 channels in the vasculature. Our data confirmed a reduced 409 
expression of KCNQ1 and KCNQ4, but not KCNQ5 in lungs from HIV-1 Tg26. We also tested the 410 
effects of the selective Kv7.1 activator L364,373 and retigabine (which activates Kv7.2 through 411 
Kv7.5). We observed that the electrophysiological and relaxant effects of L364,373 were 412 
reduced in PASMC from HIV-1 Tg26, while retigabine did not enhance the currents and had 413 
comparable relaxation in PA from both strains. Altogether, our data indicate that Kv7 channel 414 
(especially Kv7.1) activity and expression is impaired in mice expressing HIV-1 proteins. 415 
 416 
In conclusion, we demonstrate that the expression of HIV proteins in vivo impairs TASK-like 417 
and Kv7 channel activities but preserves Kv1.5 channel currents. Decreased Kv7 currents can 418 
be explained by downregulated gene expression of the channel and was functionally 419 
correlated with reduced vasodilation to a Kv7.1 channel activator. This negative impact of HIV 420 
proteins in pulmonary K
+
 channels, was not sufficient to induce PAH, at least in mice, but may 421 
play a permissive or accessory role in the pathophysiology of HIV-associated PAH. 422 
 423 
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Figure captions 599 
Fig.1. K
+
 channel activity is reduced in PASMC from Tg26 mice. A: Representative current traces 600 
for 200 ms depolarization pulses from -60 mV to +20 mV in 10 mV increments from a holding 601 
potential of -60 mV in PASMC from Wt or Tg26 PA. B: Current-voltage relationships of K+ 602 
currents measured at the end of the pulse in myocytes from Wt (n=32 from 11 different 603 
animals) or Tg26 (n=26, from 9 different animals). C: Resting membrane potential values in 604 
PASMC from Wt (n=46 from 13 different animals) or Tg26 (n=40, from 12 different animals).  *, 605 
and *** indicate P < 0.05 and P< 0.001 vs Wt; nested ANOVA. 606 
 607 
Fig.2. Kv1.5 channel activity is not altered in PASMC from Tg26 mice. A and B: Representative 608 
current traces obtained when applying a depolarizing pulse to +20 mV before (black) and after 609 
(grey) the addition of the Kv1.5 channel blocker DPO-1 (10
-6 
M). Lower panel shows the 610 
current-voltage relationships of K
+
 currents measured at the end of the pulse before and after 611 
the addition of DPO-1 in myocytes from Wt (n=7 from 6 different animals) or Tg26 (n=7, from 5 612 
different animals), respectively. *and *** indicate P < 0.05 and P< 0.001 vs in the absence of 613 
DPO-1; nested ANOVA. C: Mean data of the DPO-1-sensitive currents obtained by subtracting 614 
the current in the absence and in the presence of the drug. D and E: Representative traces and 615 
averaged values of the contractile response induced by DPO-1 in PA from Wt and Tg26 mice. F 616 
and G: KCNA5 mRNA expression by RT-PCR in Wt and Tg26 whole lung or PASMC 617 
homogenates, respectively. Results are means ± SEM of 4-5 samples, normalized by the 618 
expression of ACTB. 619 
 620 
Fig.3. Loss of TASK currents in PASMC from HIV-1 Tg26. A and B: Ramp protocol and original IKN 621 
recorded in PASMC from Wt or Tg26 mice. Representative traces recorded at pH 7.3 (black) 622 
and after changing to pH 6.3 (grey) are shown. B: Current-voltage relationships of the pH-623 
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sensitive current obtained by measuring the difference in K
+
 current at external pH values of 624 
7.3 and 6.3 in PASMC from Wt (n=7 from 6 different animals) or Tg26 (n=7, from 5 different 625 
animals). C: Graph showing pH-sensitive current at 0 mV. ** indicate P < 0.01 vs Wt. D: Original 626 
recordings (D and E) of the effects of switching the pH of the external solution from 7.3 to 6.3 627 
on membrane potential. F: Acid-induced membrane depolarization in PASMC from Wt or Tg26 628 
mice (n=7 from 6 different animals) or Tg26 (n=8, from 5 different animals), respectively. *** 629 
indicate P < 0.001 vs Wt.  F and H:  Graphs show KCNK3 mRNA expression by RT-PCR in lungs 630 
or PASMC, respectively, from WT or Tg26 mice. Results are means ± SEM of 3-4 samples, 631 
normalized by the expression of ACTB. 632 
 633 
 634 
Fig.4. Kv7 currents are reduced in PASMC from Tg26 mice. A: Representative current traces 635 
and current-voltage relationships of K
+
 currents measured at the end of the 4s depolarization 636 
pulses from -60 mV to +20 mV in 10 mV increments from a holding potential of -60 mV in 637 
PASMC from Wt (n=31 from 14 different animals) or Tg26 (n=30, from 8 different animals). B:  638 
Representative current traces at +20 mV (B) and current-voltage relationships (C and D) of K
+
 639 
currents measured at the end of the pulse before and after the addition of the Kv7 channel 640 
blocker XE991 (3x10
-7 
M) in myocytes from Wt (n=7 from 5 different animals) or Tg26 (n=6, 641 
from 5 different animals), respectively. *, ** and *** indicate P < 0.05, 0.01 and 0.001, 642 
respectively vs in the absence of XE991. E: Mean data of the XE991-sensitive currents obtained 643 
by subtracting the current in the absence and in the presence of the drug. *and ** indicate P < 644 
0.05 and P< 0.01 vs Wt. Original recordings (F) and mean data (G and H) of the 645 
vasoconstriction induced by XE991 (n=5-7) and linopirdine (n=4-5), respectively. * and ** 646 
indicate P < 0.05 and P< 0.01 vs Wt. 647 
 648 
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Fig.5. Attenuated expression of and activity of Kv7.1 channels in PA from Tg26 mice. A: KCNQ1, 649 
KCNQ4 and KCNQ5 mRNA expression by RT-PCR in Wt and Tg26 lungs. Results are means ± 650 
SEM of 4-5 samples, normalized by the expression of ACTB. * indicates P<0.05 vs Wt. B and C: 651 
Representative current traces at +20 mV and current density before and after the addition of 652 
the Kv7.1 channel activator L364,373 (10
-5 
M) in PASMC from Wt (n=6, from 3 different 653 
animals) and Tg26 mice (n=4, from 3 different animals), respectively. D and E: Original 654 
recordings and mean data of the relaxation induced by L-364,373 in serotonin-stimulated PA 655 
from Wt (n=8) or Tg26 (n=7). Results are means ± SEM. * indicate P < 0.05 vs Wt. 656 
 657 
Fig 6. Electrophysiological and relaxant effects induced by retigabine. A and B: current density 658 
at + 20 mV before and after the addition of the Kv7.2-Kv7.4 channel activator retigabine (10
-5 
659 
M) in PASMC from Wt (n=4, from 3 different animals) and Tg26 mice (n=4, from 3 different 660 
animals), respectively. D and E: Original recordings and mean data of the relaxation induced by 661 
retigabine in serotonin-stimulated PA from Wt (n=9) or Tg26 (n=8). Results are means ± SEM. 662 
 663 
Fig. 7. Tg26 mice do not exhibit pulmonary hypertension A: Original recordings of pulmonary 664 
arterial pressure in Wt (grey) and Tg26 (black) mice. B: Graphs showing means ± SEM of mean, 665 
systolic and diastolic pulmonary arterial pressure (PAP), respectively, in Wt and Tg26 mice. 666 
Results are means ± SEM (n=8-10). C and D: Graphs showing means ±SEM of right ventricular 667 
systolic pressure (RVSP) and heart rate, respectively, in Wt and Tg26 mice. E: Right ventricular 668 
(RV) weight relative to left ventricle + septum (LV+S) or to body weight (RV/BW), respectively. 669 
Results are means ± SEM (n=10).   670 
 671 
Fig. 8. Endothelial dependent relaxation is impaired in PA from HIV-1 Tg26 mice. A: 672 
Vasoconstrictor responses induced by KCl. B: Original recordings and mean data (C) of the 673 
vasoconstriction induced serotonin (5-HT). D and E: Relaxation induced by Acetylcholine (ACh) 674 
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or sodium nitroprusside (SNP), respectively in serotonin-stimulated PA. F: Relaxation induced 675 
by Acetylcholine (Ach) in serotonin-stimulated mesenteric arteries. Results are means ± SEM. * 676 
and ** indicate P<0.05 and P<0.01 versus Wt (n = 5-6 mice per group). 677 
 678 
Fig. 9. Tg26 mice exhibit a modest pulmonary vascular remodeling. A: Representative 679 
hematoxylin and eosin staining of paraffin-embedded lung sections from the Wt and Tg26 680 
mice. B: Percentage of muscular, partially muscular and non-muscular PA in Wt and Tg26 mice. 681 
C: Representative photomicrographs of elastica Van Gieson staining. D: % wall thickness of 682 
ƉƵůŵŽŶĂƌǇ ǀĞƐƐĞůƐ ŝŶ tƚ ĂŶĚ dŐ ? ? ŵŝĐĞ  ?ŶറA?റ ? ƉĞƌ ŐƌŽƵƉ ? ?  ƚŽƚal of 495-500 vessels were 683 
measured per group. Scale bars = 50 µm.  684 
  685 
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Table 1. List of primers used. 686 
Primer Name Assay ID &ŽƌǁĂƌĚ ? ? ?-3) Reverse (5´-3´) 
HIV-1 Transgene  TCCAGTTTGGAAAGGACCAG TTGCCACACAATCATCACCT 
Positive control  
CTCCCAACCCCAGAGGTAGT AGACCCCAGATCCAGAAAGG 
KCNA5 Mm00524346_s1   
KCNK3 Mm04213388_s1   
KCNQ1 Mm00434640_s1   
KCNQ4 Mm01185500_m1   
KCNQ5 Mm00524346_s1   
Actb Mm02619580_g1   
NOS3  GGTATTTGATGCTCGGGACT TGTGGTTACAGATGTAGGTGAACA 
BMPR2  GAGCCCTCCCTTGACCTG GTATCGACCCCGTCCAATC 
 687 
 688 
  689 
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Table 2. Noninvasive estimation of hemodynamic parameters in Wt and Tg26 mice by Doppler 690 
echocardiography. 691 
 Wt Tg26 
PAT, ms 16.53 ± 1.03 16.53 ± 0.21 
ET, ms 57.41 ± 2.04 61.76 ± 1.99 
PAT/ET (%) 28.98 ± 2.03 26.88 ± 0.78 
TAPSE (cm) 10,5 ± 0.5 10,5 ± 1 
 692 
 693 
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